Avidin’s CEO László Puskás and Head of International Relations Klára Kitajka are participating at BIO 2019 https://convention.bio.org/ to access to global biotech and pharma One-on-One Partnering and for unparalleled networking opportunities with 16,000+ attendees from 74 countries. Avidin’s main focus is to find partners for its drug development pipeline, including neurodegeneration, asthma/COPD and cancer indications.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions and biotechnology centers in more than 30 other nations. Participants are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.